HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Bank of Montreal Can

Bank of Montreal Can reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 4.5% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 286,634 shares of the company’s stock after selling 13,662 shares during the period. Bank of Montreal Can’s holdings in HCA Healthcare were worth $115,593,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of HCA. Bangor Savings Bank raised its position in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new stake in HCA Healthcare in the second quarter valued at $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare during the 2nd quarter worth $28,000. GPS Wealth Strategies Group LLC raised its stake in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. bought a new stake in HCA Healthcare in the second quarter valued at about $33,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 in the last quarter. Insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Performance

HCA opened at $328.95 on Wednesday. HCA Healthcare, Inc. has a 1-year low of $245.84 and a 1-year high of $417.14. The company has a market capitalization of $83.32 billion, a price-to-earnings ratio of 14.77, a price-to-earnings-growth ratio of 1.25 and a beta of 1.68. The business has a 50 day moving average price of $376.47 and a two-hundred day moving average price of $358.74. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Analysts Set New Price Targets

HCA has been the subject of a number of research analyst reports. UBS Group boosted their price target on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Oppenheimer increased their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price objective for the stock from $400.00 to $320.00 in a research note on Monday. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, Morgan Stanley assumed coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price objective for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $380.29.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.